Jackson DB - Search Results

1

Molecular perspectives on the non-responder phenomenon.

Jackson DB. Jackson DB. Drug Discov Today. 2009 Apr;14(7-8):373-9. doi: 10.1016/j.drudis.2009.01.005. Epub 2009 Feb 4. Drug Discov Today. 2009. PMID: 19200455 Review.

2

Clinical and economic impact of the nonresponder phenomenon--implications for systems based discovery.

Jackson DB. Jackson DB. Drug Discov Today. 2009 Apr;14(7-8):380-5. doi: 10.1016/j.drudis.2009.01.006. Epub 2009 Feb 5. Drug Discov Today. 2009. PMID: 19200855 Review.

3

Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.

Picker A, Jackson DB. Picker A, et al. Among authors: jackson db. Expert Rev Mol Diagn. 2011 Jul;11(6):567-77. doi: 10.1586/erm.11.45. Expert Rev Mol Diagn. 2011. PMID: 21745011 Review.

4

Use of "big data" in drug discovery and clinical trials.

Taglang G, Jackson DB. Taglang G, et al. Among authors: jackson db. Gynecol Oncol. 2016 Apr;141(1):17-23. doi: 10.1016/j.ygyno.2016.02.022. Gynecol Oncol. 2016. PMID: 27016224

5

Personalized cancer medicine--advances and socio-economic challenges.

Jackson DB, Sood AK. Jackson DB, et al. Nat Rev Clin Oncol. 2011 Oct 11;8(12):735-41. doi: 10.1038/nrclinonc.2011.151. Nat Rev Clin Oncol. 2011. PMID: 21989071 Free PMC article. Review.

6

Precision Oncology-The Quest for Evidence.

Soldatos TG, Kaduthanam S, Jackson DB. Soldatos TG, et al. Among authors: jackson db. J Pers Med. 2019 Sep 5;9(3):43. doi: 10.3390/jpm9030043. J Pers Med. 2019. PMID: 31492009 Free PMC article. Review.

7

Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer.

Malgerud L, Lindberg J, Wirta V, Gustafsson-Liljefors M, Karimi M, Moro CF, Stecker K, Picker A, Huelsewig C, Stein M, Bohnert R, Del Chiaro M, Haas SL, Heuchel RL, Permert J, Maeurer MJ, Brock S, Verbeke CS, Engstrand L, Jackson DB, Grönberg H, Löhr JM. Malgerud L, et al. Among authors: jackson db. Mol Oncol. 2017 Oct;11(10):1413-1429. doi: 10.1002/1878-0261.12108. Epub 2017 Aug 8. Mol Oncol. 2017. PMID: 28675654 Free PMC article.

8

Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports.

Soldatos TG, Kim S, Schmidt S, Lesko LJ, Jackson DB. Soldatos TG, et al. Among authors: jackson db. CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):540-555. doi: 10.1002/psp4.12765. Epub 2022 Feb 20. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35143713 Free PMC article. Review.

9

Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar.

Sachpekidis C, Jackson DB, Soldatos TG. Sachpekidis C, et al. Among authors: jackson db. Pharmaceuticals (Basel). 2019 Sep 20;12(4):141. doi: 10.3390/ph12040141. Pharmaceuticals (Basel). 2019. PMID: 31546999 Free PMC article.

10

Adverse Event Circumstances and the Case of Drug Interactions.

Soldatos TG, Jackson DB. Soldatos TG, et al. Among authors: jackson db. Healthcare (Basel). 2019 Mar 19;7(1):45. doi: 10.3390/healthcare7010045. Healthcare (Basel). 2019. PMID: 30893930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

252 results

Search Page